+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Cystatin C Assay Market by Product (Analyzer, Kits, Reagents), Method (Chemiluminescence Immunoassay, Enzyme linked Immunosorbent Assay, Immunofluorescence Assay), Sample Type, Setting, Application, End-user - Forecast 2024-2030- Product Image
Global Cystatin C Assay Market by Product (Analyzer, Kits, Reagents), Method (Chemiluminescence Immunoassay, Enzyme linked Immunosorbent Assay, Immunofluorescence Assay), Sample Type, Setting, Application, End-user - Forecast 2024-2030- Product Image
Sale

Global Cystatin C Assay Market by Product (Analyzer, Kits, Reagents), Method (Chemiluminescence Immunoassay, Enzyme linked Immunosorbent Assay, Immunofluorescence Assay), Sample Type, Setting, Application, End-user - Forecast 2024-2030

  • PDF Icon

    Report

  • 182 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5914462
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cystatin C Assay Market size was estimated at USD 427.47 million in 2023, USD 459.83 million in 2024, and is expected to grow at a CAGR of 7.24% to reach USD 697.41 million by 2030.

The cystatin C assay is a laboratory test utilized to measure the levels of cystatin C, a protein produced by nearly all cells in the body. It is most useful in exceptional cases where creatinine measurement could be misleading. The increasing prevalence of kidney diseases and the growing geriatric population drive the need for cystatin C assay. Furthermore, the increasing availability and clinical adoption of cystatin C with the introduction of advanced automated testing methods have led to its market growth.

In contrast, the high manufacturing costs of cystatin C assays and strict interpretation guidelines restrict their adoption. However, several vendors are investing in R&D to overcome its issues. Furthermore, advancements in diagnostics technologies, emerging research, and ongoing publishing of clinical guidelines for cystatin C assay provide substantial market growth opportunities.

Regional Insights

In North America, particularly in the U.S., the presence of major healthcare and diagnostic companies, research institutions, and well-established healthcare infrastructure is a significant contributor to the cystatin C assay market. Moreover, stringent regulatory standards laid by government regulatory agencies, including the U.S. Food and Drug Administration (FDA) and Health Canada, play a crucial role in product approvals for cystatin c assay. In South America, increasing awareness about the importance of early disease diagnosis and a growing healthcare sector is expected to contribute to the expanding need for cystatin C assay.

In Europe, countries such as Germany, France, Switzerland, and the United Kingdom are contributing to the growing adoption of cystatin C assay as they have well-established healthcare infrastructure with high spending and a focus on technological advancements in the pharmaceutical and biotechnology sectors. In the Middle East and Africa, the growing prevalence of chronic diseases with increasing population and a focus on improving diagnostic capabilities with investing heavily in the healthcare sector is expected to bolster the usage of cystatin C assay in the region. In APAC countries, including China and Japan, the increasing number of geriatric residents and the rising prevalence of chronic diseases contribute to the expansion of the market. In countries including China, India, and Australia, increasing awareness of kidney diseases and proactive health screening initiatives by government and regional healthcare companies increase the need for diagnostic tests such as cystatin c assay. In emerging nations such as Indonesia, Thailand, and Vietnam, economic development, expanding healthcare access, and an emphasis on preventive healthcare support the application of cystatin C assay in the region.

Market Trends by Segment

  • Product: Consumer preference cystatin C analyzer for diagnosis and monitoring conditions
  • Method: Expanding usage of enzyme-linked immunosorbent assay (ELISA) for cystatin C assays
  • Setting: Expanding usage of point-of-care setting for cystatin C assays
  • Sample Type: Significant role urine sample for cystatin C assay for measuring the amount of creatinine in a sample
  • Application: Increasing application of cystatin C assays for diagnosis of renal function
  • End-user: Expanding usage of cystatin C assays in academic research centers for studying biomarkers

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Jana Care Raises USD 6 Million for Commercialisation of Self-Administered Blood Tests

Jana Care raised USD 6 million in Series B funding to support the commercialization of its self-administered blood tests for kidney and heart disease. The funds further enhance Jana Care's quantitative blood testing platform. This platform is designed to enable individuals to self-administer tests at home while facilitating remote review by healthcare professionals.

LordsMed Announces the Launch of its First Pathology Centre in Maharashtra

LordsMed, the healthcare division of Lords Mark Industries Pvt. Ltd., launched pathology centers in Kalyan and Dombivli. The company has plans to open ten more centers in and around Mumbai by December 2023. The establishment of this pathology center greatly facilitates patient access to critical diagnostic tests, ultimately improving healthcare outcomes.

Renalyse Closes a EUR 1 Million Funding Round with the Participation of GENESIS Ventures

Renalyse, a company dedicated to developing innovative bioanalytical assays, recently concluded a successful EUR 1 million funding round with Genesis Ventures. The investment round aims to support the industrialization and certification of Renalyse's diagnostic and monitoring device for chronic kidney disease.

Key Company Profiles

The report delves into recent significant developments in the Cystatin C Assay Market, highlighting leading vendors and their innovative profiles. These include Abbexa Limited, Abbott Laboratories, Abcam PLC, Advy Chemical Pvt. Ltd., Agilent Technologies, Inc., AOBIOUS Inc., Arbor Assays Inc., Aviva Systems Biology Corporation, BBI Solutions OEM Limited, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Biorbyt Ltd, BioVendor - Laboratorní medicína a.s., Boditech Med Inc., Cepham Life Sciences, Inc., Cusabio Technology LLC, DIALAB GmbH, DiaSys Diagnostic Systems GmbH, Diazyme Laboratories, Inc. by General Atomics, Eagle Biosciences, Inc., Elabscience Biotechnology Inc., Ethos Biosciences, Inc., Eurolyser Diagnostica GmbH by Mars, Incorporated, F. Hoffmann-La Roche Ltd, Fapon Biotech Inc., Fortress Diagnostics Ltd., Gentian Diagnostics ASA, Getein Biotech, Inc., ImmunoDiagnostics Limited, Kamiya Biomedical Company, Laboratory Corporation of America Holdings, Merck KGaA, Proteintech Group, Inc., PZ CORMAY S.A., Randox Laboratories Ltd., RayBiotech, Inc., Sekisui Diagnostics, LLC, Siemens Healthineers AG, Sino Biological, Inc., Thermo Fisher Scientific Inc., Tosoh Corporation, Weldon Biotech, and Zhejiang Kangte Biotechnology Co., Ltd.

This research report offers invaluable insights into various crucial aspects of the Cystatin C Assay Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of kidney diseases and growing geriatric population
5.1.1.2. Progressive investments in healthcare infrastructures for renal disorders
5.1.2. Restraints
5.1.2.1. High development costs of cystatin C assays and incidences of product recalls
5.1.3. Opportunities
5.1.3.1. Advances in cystatin C assay testing
5.1.3.2. Emerging research for adoption of cystatin C assays as alternative to creatinine-based tests
5.1.4. Challenges
5.1.4.1. Dearth of skilled lab professionals and technical challenges associated with cystatin C assay
5.2. Market Segmentation Analysis
5.2.1. Product: Consumer preference cystatin C analyzer for diagnosis and monitoring conditions
5.2.2. Method: Expanding usage of enzyme-linked immunosorbent assay (ELISA) for cystatin C assays
5.2.3. Setting: Expanding usage of point-of-care setting for cystatin C assays
5.2.4. Sample Type: Significant role urine sample for cystatin C assay for measuring the amount of creatinine in a sample
5.2.5. Application: Increasing application of cystatin C assays for diagnosis of renal function
5.2.6. End-user: Expanding usage of cystatin C assays in academic research centers for studying biomarkers
5.3. Market Trend Analysis
5.3.1. Well-established healthcare infrastructure coupled with emphasis on commercializing Cystatin C Assay solutions in the Americas
5.3.2. Supportive government programs to reduce the burden of renal disorders in the Asia-Pacific region
5.3.3. Growing focus on developing and expanding novel cystatin C assays products in the EMEA region
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
6. Cystatin C Assay Market, by Product
6.1. Introduction
6.2. Analyzer
6.3. Kits
6.4. Reagents
7. Cystatin C Assay Market, by Method
7.1. Introduction
7.2. Chemiluminescence Immunoassay
7.3. Enzyme linked Immunosorbent Assay
7.4. Immunofluorescence Assay
7.5. Particle-enhanced Nephelometric Immunoassay
7.6. Particle-enhanced Turbidimetric Immunoassay
8. Cystatin C Assay Market, by Sample Type
8.1. Introduction
8.2. Blood
8.3. Urine
9. Cystatin C Assay Market, by Setting
9.1. Introduction
9.2. Laboratory Setting
9.3. Point of Care Setting
10. Cystatin C Assay Market, by Application
10.1. Introduction
10.2. Diagnosis Use
10.3. Research & Development
11. Cystatin C Assay Market, by End-user
11.1. Introduction
11.2. Academic Research Centers
11.3. Diagnostic Laboratories
11.4. Hospitals & Clinics
12. Americas Cystatin C Assay Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Cystatin C Assay Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Cystatin C Assay Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2023
15.2. FPNV Positioning Matrix, 2023
15.3. Competitive Scenario Analysis
15.3.1. Jana Care Raises USD 6 Million for Commercialisation of Self-Administered Blood Tests
15.3.2. LordsMed Announces the Launch of its First Pathology Centre in Maharashtra
15.3.3. Renalyse Closes a EUR 1 Million Funding Round with the Participation of GENESIS Ventures
15.3.4. Renalytix Selects EVERSANA to Expand Commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 Diabetes
15.3.5. New European Cystatin C Equation for eGFR May Be More Accurate
15.3.6. Jana Care to Enter Collaboration with Roche to Develop and Distribute Blood Testing Platform to Improve Remote Care for Patients With Chronic Kidney and Heart Disease
15.3.7. Gentian Diagnostics ASA Signs Distribution Agreement for Cystatin C
15.3.8. Bloom Diagnostics Launches New Kidney Test
16. Competitive Portfolio
16.1. Key Company Profiles
16.2. Key Product Portfolio
List of Figures
FIGURE 1. CYSTATIN C ASSAY MARKET RESEARCH PROCESS
FIGURE 2. CYSTATIN C ASSAY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CYSTATIN C ASSAY MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 4. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 6. CYSTATIN C ASSAY MARKET DYNAMICS
FIGURE 7. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 9. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
FIGURE 10. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 11. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
FIGURE 12. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 13. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2023 VS 2030 (%)
FIGURE 14. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 15. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 16. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 17. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 18. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 19. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 21. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 22. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 23. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 27. CYSTATIN C ASSAY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 28. CYSTATIN C ASSAY MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CYSTATIN C ASSAY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CYSTATIN C ASSAY MARKET SIZE, 2018-2023 (USD THOUSAND)
TABLE 4. GLOBAL CYSTATIN C ASSAY MARKET SIZE, 2024-2030 (USD THOUSAND)
TABLE 5. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 6. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 7. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 8. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 9. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY ANALYZER, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 10. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY ANALYZER, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 11. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY KITS, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 12. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY KITS, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 13. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 14. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY REAGENTS, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 15. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
TABLE 16. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
TABLE 17. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 18. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 19. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 20. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 21. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY IMMUNOFLUORESCENCE ASSAY, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 22. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY IMMUNOFLUORESCENCE ASSAY, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 23. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 24. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 25. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 26. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 27. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
TABLE 28. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
TABLE 29. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY BLOOD, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 30. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY BLOOD, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 31. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY URINE, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 32. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY URINE, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 33. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
TABLE 34. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
TABLE 35. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY LABORATORY SETTING, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 36. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY LABORATORY SETTING, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 37. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY POINT OF CARE SETTING, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 38. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY POINT OF CARE SETTING, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 39. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 40. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 41. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY DIAGNOSIS USE, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 42. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY DIAGNOSIS USE, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 43. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 44. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 45. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 46. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 47. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY ACADEMIC RESEARCH CENTERS, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 48. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY ACADEMIC RESEARCH CENTERS, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 49. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 50. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 51. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 52. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 53. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 54. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 55. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
TABLE 56. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
TABLE 57. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
TABLE 58. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
TABLE 59. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
TABLE 60. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
TABLE 61. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 62. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 63. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 64. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 65. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2018-2023 (USD THOUSAND)
TABLE 66. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2024-2030 (USD THOUSAND)
TABLE 67. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 68. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 69. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
TABLE 70. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
TABLE 71. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
TABLE 72. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
TABLE 73. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
TABLE 74. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
TABLE 75. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 76. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 77. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 78. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 79. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 80. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 81. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
TABLE 82. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
TABLE 83. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
TABLE 84. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
TABLE 85. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
TABLE 86. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
TABLE 87. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 88. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 89. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 90. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 91. CANADA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 92. CANADA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 93. CANADA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
TABLE 94. CANADA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
TABLE 95. CANADA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
TABLE 96. CANADA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
TABLE 97. CANADA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
TABLE 98. CANADA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
TABLE 99. CANADA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 100. CANADA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 101. CANADA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 102. CANADA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 103. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 104. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 105. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
TABLE 106. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
TABLE 107. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
TABLE 108. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
TABLE 109. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
TABLE 110. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
TABLE 111. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 112. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 113. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 114. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 115. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 116. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 117. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
TABLE 118. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
TABLE 119. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
TABLE 120. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
TABLE 121. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
TABLE 122. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
TABLE 123. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 124. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 125. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 126. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 127. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY STATE, 2018-2023 (USD THOUSAND)
TABLE 128. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY STATE, 2024-2030 (USD THOUSAND)
TABLE 129. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 130. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 131. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
TABLE 132. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
TABLE 133. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
TABLE 134. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
TABLE 135. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
TABLE 136. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
TABLE 137. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 138. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 139. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 140. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 141. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2018-2023 (USD THOUSAND)
TABLE 142. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2024-2030 (USD THOUSAND)
TABLE 143. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 144. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 145. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
TABLE 146. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
TABLE 147. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
TABLE 148. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
TABLE 149. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
TABLE 150. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
TABLE 151. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 152. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 153. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 154. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 155. CHINA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 156. CHINA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 157. CHINA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
TABLE 158. CHINA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
TABLE 159. CHINA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
TABLE 160. CHINA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
TABLE 161. CHINA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
TABLE 162. CHINA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
TABLE 163. CHINA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 164. CHINA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 165. CHINA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 166. CHINA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 167. INDIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 168. INDIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 169. INDIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
TABLE 170. INDIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
TABLE 171. INDIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
TABLE 172. INDIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
TABLE 173. INDIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
TABLE 174. INDIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
TABLE 175. INDIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 176. INDIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 177. INDIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 178. INDIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 179. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 180. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 181. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
TABLE 182. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
TABLE 183. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
TABLE 184. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
TABLE 185. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
TABLE 186. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
TABLE 187. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 188. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 189. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 190. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 191. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 192. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 193. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
TABLE 194. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
TABLE 195. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
TABLE 196. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
TABLE 197. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
TABLE 198. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
TABLE 199. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 200. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 201. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 202. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 203. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 204. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 205. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
TABLE 206. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
TABLE 207. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
TABLE 208. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
TABLE 209. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
TABLE 210. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
TABLE 211. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 212. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 213. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 214. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 215. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 216. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 217. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
TABLE 218. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
TABLE 219. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
TABLE 220. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
TABLE 221. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
TABLE 222. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
TABLE 223. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 224. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 225. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 226. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 227. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 228. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 229. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
TABLE 230. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
TABLE 231. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
TABLE 232. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
TABLE 233. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
TABLE 234. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
TABLE 235. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 236. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 237. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 238. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 239. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 240. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 241. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
TABLE 242. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
TABLE 243. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
TABLE 244. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
TABLE 245. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
TABLE 246. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
TABLE 247. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 248. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 249. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 250. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 251. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 252. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 253. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
TABLE 254. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
TABLE 255. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
TABLE 256. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
TABLE 257. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
TABLE 258. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
TABLE 259. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 260. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 261. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 262. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 263. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 264. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 265. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
TABLE 266. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
TABLE 267. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
TABLE 268. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
TABLE 269. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
TABLE 270. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
TABLE 271. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 272. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 273. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 274. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 275. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 276. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 277. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
TABLE 278. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
TABLE 279. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
TABLE 280. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
TABLE 281. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
TABLE 282. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
TABLE 283. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 284. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 285. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 286. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2018-2023 (USD THOUSAND)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2024-2030 (USD THOUSAND)
TABLE 301. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 302. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 303. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
TABLE 304. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
TABLE 305. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
TABLE 306. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
TABLE 307. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
TABLE 308. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
TABLE 309. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 310. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 311. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 312. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 313. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 314. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 315. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
TABLE 316. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
TABLE 317. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
TABLE 318. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
TABLE 319. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
TABLE 320. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
TABLE 321. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 322. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 323. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 324. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 325. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 326. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 327. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
TABLE 328. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
TABLE 329. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
TABLE 330. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
TABLE 331. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
TABLE 332. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
TABLE 333. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 334. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 335. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 336. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 337. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 338. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 339. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
TABLE 340. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
TABLE 341. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
TABLE 342. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
TABLE 343. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
TABLE 344. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
TABLE 345. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 346. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 347. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 348. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 349. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 350. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 351. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
TABLE 352. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
TABLE 353. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
TABLE 354. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
TABLE 355. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
TABLE 356. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
TABLE 357. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 358. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 359. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 360. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 361. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 362. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 363. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
TABLE 364. ISRAEL CYSTATIN C ASSAY

Companies Mentioned

  • Abbexa Limited
  • Abbott Laboratories
  • Abcam PLC
  • Advy Chemical Pvt. Ltd.
  • Agilent Technologies, Inc.
  • AOBIOUS Inc.
  • Arbor Assays Inc.
  • Aviva Systems Biology Corporation
  • BBI Solutions OEM Limited
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Biorbyt Ltd
  • BioVendor – Laboratorní medicína a.s.
  • Boditech Med Inc.
  • Cepham Life Sciences, Inc.
  • Cusabio Technology LLC
  • DIALAB GmbH
  • DiaSys Diagnostic Systems GmbH
  • Diazyme Laboratories, Inc. by General Atomics
  • Eagle Biosciences, Inc.
  • Elabscience Biotechnology Inc.
  • Ethos Biosciences, Inc.
  • Eurolyser Diagnostica GmbH by Mars, Incorporated
  • F. Hoffmann-La Roche Ltd
  • Fapon Biotech Inc.
  • Fortress Diagnostics Ltd.
  • Gentian Diagnostics ASA
  • Getein Biotech, Inc.
  • ImmunoDiagnostics Limited
  • Kamiya Biomedical Company
  • Laboratory Corporation of America Holdings
  • Merck KGaA
  • Proteintech Group, Inc.
  • PZ CORMAY S.A.
  • Randox Laboratories Ltd.
  • RayBiotech, Inc.
  • Sekisui Diagnostics, LLC
  • Siemens Healthineers AG
  • Sino Biological, Inc.
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation
  • Weldon Biotech
  • Zhejiang Kangte Biotechnology Co., Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages182
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 459.83 Million
Forecasted Market Value ( USD ) by 2030 $ 697.41 Million
Compound Annual Growth Rate7.2%
Regions CoveredGlobal
No. of Companies Mentioned43

Related Topics

Related Reports

Cystatin C Assay Market by Product (Analyzers, Kits, Reagents), Method (ELISA, PETIA, IFA, CLIA, PENIA), Application (Diagnostics, Research), Sample Type (Blood, Urine), End User (Hospitals, Clinical Laboratories) & Region - Global Forecast to 2028 - Product Image

Cystatin C Assay Market by Product (Analyzers, Kits, Reagents), Method (ELISA, PETIA, IFA, CLIA, PENIA), Application (Diagnostics, Research), Sample Type (Blood, Urine), End User (Hospitals, Clinical Laboratories) & Region - Global Forecast to 2028

  • Report
  • 263 Pages
  • Global
From
Cystatin C Assay Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Cystatin C Assay Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Cystatin C Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Cystatin C Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 173 Pages
  • Global
From
Global Cystatin C Assay Market: Focus on Applications, End Users, Types, Methods, Sample and Over 14 Countries' Data - Analysis and Forecast, 2024-2033 - Product Image

Global Cystatin C Assay Market: Focus on Applications, End Users, Types, Methods, Sample and Over 14 Countries' Data - Analysis and Forecast, 2024-2033

  • Report
  • 151 Pages
  • Global
From
2024 World Immunoassay Analyzers and Reagents in 98 Countries - Supplier Shares and Competitive Analysis, 2023-2028 - Product Image

2024 World Immunoassay Analyzers and Reagents in 98 Countries - Supplier Shares and Competitive Analysis, 2023-2028

  • Report
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.